203 related articles for article (PubMed ID: 12043839)
21. Studying a complex tumor: potential and pitfalls.
Zheng S; Chheda MG; Verhaak RG
Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264
[TBL] [Abstract][Full Text] [Related]
22. The basic science of brain-tumour gene therapy.
Lowenstein PR; Cowen R; Thomas C; Castro MG
Biochem Soc Trans; 1999 Dec; 27(6):873-81. PubMed ID: 10830120
[No Abstract] [Full Text] [Related]
23. [Oncolytic viral therapy of gliomas: review of the literature].
Arrese I; González P; Miranda P; Pérez-Núñez A; Pascual B; Lobato RD
Neurocirugia (Astur); 2005 Apr; 16(2):158-68. PubMed ID: 15915305
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
25. Gene Therapy 2017: Progress and Future Directions.
Keeler AM; ElMallah MK; Flotte TR
Clin Transl Sci; 2017 Jul; 10(4):242-248. PubMed ID: 28383804
[No Abstract] [Full Text] [Related]
26. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
Debinski W; Tatter SB
Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
[TBL] [Abstract][Full Text] [Related]
27. Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology.
Chiocca EA; Broaddus WC; Gillies GT; Visted T; Lamfers ML
J Neurooncol; 2004; 69(1-3):101-17. PubMed ID: 15527083
[TBL] [Abstract][Full Text] [Related]
28. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
Kinoshita Y; Kamitani H; Mamun MH; Wasita B; Kazuki Y; Hiratsuka M; Oshimura M; Watanabe T
Neurol Res; 2010 May; 32(4):429-37. PubMed ID: 19589205
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy.
Gomez-Manzano C; Jiang H; Alonso M; Yung WK; Fueyo J
Handb Clin Neurol; 2012; 104():331-8. PubMed ID: 22230451
[No Abstract] [Full Text] [Related]
30. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
Parvez T
Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
[TBL] [Abstract][Full Text] [Related]
31. Systematic Evaluation of Promising Clinical Trials-Gene Silencing for the Treatment of Glioblastoma.
Karaarslan N; Yilmaz I; Ozbek H; Caliskan T; Topuk S; Sirin DY; Ates O
Turk Neurosurg; 2019; 29(3):328-334. PubMed ID: 29694664
[TBL] [Abstract][Full Text] [Related]
32. Current status of gene therapy for brain tumors.
Murphy AM; Rabkin SD
Transl Res; 2013 Apr; 161(4):339-54. PubMed ID: 23246627
[TBL] [Abstract][Full Text] [Related]
33. The principles of molecular therapies for glioblastoma.
Karpati G; Nalbantoglu J
Int Rev Neurobiol; 2003; 55():151-63. PubMed ID: 12968535
[No Abstract] [Full Text] [Related]
34. Gendicine: the first commercial gene therapy product.
Wilson JM
Hum Gene Ther; 2005 Sep; 16(9):1014-5. PubMed ID: 16149899
[No Abstract] [Full Text] [Related]
35. Gene Delivery in Neuro-Oncology.
Dixit K; Kumthekar P
Curr Oncol Rep; 2017 Sep; 19(11):69. PubMed ID: 28866732
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.
Wei X; Lv T; Chen D; Guan J
Technol Cancer Res Treat; 2014 Feb; 13(1):87-93. PubMed ID: 23883433
[TBL] [Abstract][Full Text] [Related]
37. [Epigenetic regulation in glioblastomas].
Quillien V
Ann Pathol; 2009 Nov; 29 Spec No 1():S34-6. PubMed ID: 19887247
[No Abstract] [Full Text] [Related]
38. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
Huszthy PC; Svendsen A; Wilson JM; Kotin RM; Lønning PE; Bjerkvig R; Hoover F
Hum Gene Ther; 2005 Mar; 16(3):381-92. PubMed ID: 15812233
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
[TBL] [Abstract][Full Text] [Related]
40. Advances in gene therapy and immunotherapy for brain tumors.
Kew Y; Levin VA
Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
